Error loading player: No playable sources found
Panel Discussion – Question and Answers
Date
January 28, 2021
This product is not available for individual purchase, but it is available as part of the following products:
Panelists
Health Canada
Harvard Medical School; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center
Baylor College of Medicine
Pfizer, Inc.
CBER, FDA
CBER, FDA
European Medicines Agency (EMA)
Related Products
New Perspectives for the Characterization of Nano-vaccines and Nanopharmaceuticals using Field-flow Fractionation Coupled to Multiple Detectors (MD-AF4) - Technical Seminar Sponsored by Wyatt Technology Corporation
Nanopharmaceuticals and nanoparticle-based vaccines are of increasing importance in the pharmaceutical industry…
Impact of COVID-19 on Next Generation Sequencing Applications for Adventitious Agent Detection in Viral Vaccine Manufacturing
Next generation sequencing (NGS) has capabilities for sensitive and broad virus detection and therefore can potentially substitute or replace the current adventitious virus detection assays…
Lessons Learned from the Pandemic: What Might the Future Bring? Workshop Session Eight
Since the pandemic began, biopharmaceutical companies have been partnering with government and
